Safety profile of durvalumab (D) as consolidation treatment (tx) in limited-stage small-cell lung cancer (LS-SCLC) in ADRIATIC: Focus on pneumonitis and immune mediated adverse events (imAEs) Meeting Abstract
| Authors: | Iyengar, P.; Cheng, Y.; Spigel, D.; Cho, B. C.; Laktionov, K.; Chen, Y.; Lee, K. H.; Buchmeier, E.; Villanueva Palicio, N.; Okamoto, I.; Badzio, A.; Shi, A.; Lu, S.; Özgüroglu, M.; Ohe, Y.; Bernabe, R.; Gill, B.; Chugh, P.; Gowda, H.; Senan, S. |
| Abstract Title: | Safety profile of durvalumab (D) as consolidation treatment (tx) in limited-stage small-cell lung cancer (LS-SCLC) in ADRIATIC: Focus on pneumonitis and immune mediated adverse events (imAEs) |
| Meeting Title: | 66th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2024) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 120 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2024 Sep 29-Oct 2 |
| Meeting Location: | Washington, DC |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | S8 |
| End Page: | S9 |
| Language: | English |
| ACCESSION: | WOS:001325892302459 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.ijrobp.2024.08.024 |
| Notes: | Meeting Abstract: LBA 13 -- Source: Wos |
